Suppr超能文献

中医师患肾癌及其他泌尿器官癌症的死亡风险增加。

Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists.

作者信息

Yang Hsiao-Yu, Wang Jung-Der, Lo Tsai-Chang, Chen Pau-Chung

机构信息

Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan.

出版信息

J Epidemiol. 2009;19(1):17-23. doi: 10.2188/jea.je20080035. Epub 2009 Jan 22.

Abstract

BACKGROUND

A national survey in Taiwan has shown that Chinese herbal therapy increases the risk of chronic kidney disease. However, it is unknown whether herbal therapy will increase the risk of urological cancers. The purpose of this study was to determine whether Chinese herbalists are at higher risk for urological cancers.

METHODS

We studied all Chinese herbalists in Taiwan that were registered in the Chinese Herbalist Labor Union between 1985 and 2000. We retrospectively followed their survival status and causes of death using the National Mortality Registry Database from 1985 to 2004. Standardized mortality ratios (SMRs) for urological cancers in herbalists were calculated and compared with those of the general population of Taiwan.

RESULTS

A total of 6548 Chinese herbalists were enrolled and 88,289 person-years were accrued during the observation period. After adjustment for age and sex, the SMR for urological cancers was significantly higher for Chinese herbalists than for the general population (SMR = 3.10; 95% CI: 1.41-5.87). When further stratified by location, the SMR for kidney cancer and other urinary organ cancers (SMR = 3.81; 95% CI: 1.39-8.28) except bladder cancer (SMR = 2.26; 95% CI: 0.47-6.59) were significantly higher for the Chinese herbalists. The SMR for chronic and unspecified nephritis, renal failure, and renal sclerosis were also significantly higher for herbalists (SMR = 2.40; 95% CI: 1.40-3.84).

CONCLUSIONS

Chinese herbalists have a significantly higher risk for urological cancers. This increased risk among herbalists highlights the urgent need for safety assessments of Chinese herbs.

摘要

背景

台湾的一项全国性调查显示,中草药疗法会增加慢性肾病的风险。然而,尚不清楚草药疗法是否会增加泌尿系统癌症的风险。本研究的目的是确定中医师患泌尿系统癌症的风险是否更高。

方法

我们研究了1985年至2000年期间在中医师工会注册的台湾所有中医师。我们使用1985年至2004年的国家死亡率登记数据库回顾性地跟踪他们的生存状况和死亡原因。计算中医师泌尿系统癌症的标准化死亡率(SMR),并与台湾普通人群的进行比较。

结果

共纳入6548名中医师,观察期内累积人年数为88289人年。在调整年龄和性别后,中医师泌尿系统癌症的SMR显著高于普通人群(SMR = 3.10;95% CI:1.41 - 5.87)。按地点进一步分层时,除膀胱癌(SMR = 2.26;95% CI:0.47 - 6.59)外,中医师肾癌和其他泌尿器官癌症的SMR(SMR = 3.81;95% CI:1.39 - 8.28)显著更高。中医师慢性和未特定的肾炎、肾衰竭及肾硬化的SMR也显著更高(SMR = 2.40;95% CI:1.40 - 3.84)。

结论

中医师患泌尿系统癌症的风险显著更高。中医师中这种增加的风险凸显了对中草药进行安全性评估的迫切需求。

相似文献

引用本文的文献

2
Kidney Cancer Integrative Oncology: Possible Options for Care.肾癌综合肿瘤学:可能的护理选择。
Curr Oncol Rep. 2023 Sep;25(9):1071-1080. doi: 10.1007/s11912-023-01437-x. Epub 2023 Jul 19.
4
Cancer in Korean patients with end-stage renal disease: A 7-year follow-up.韩国终末期肾病患者的癌症:7年随访
PLoS One. 2017 Jul 10;12(7):e0178649. doi: 10.1371/journal.pone.0178649. eCollection 2017.
8
Association of dialysis with the risks of cancers.透析与癌症风险的关联。
PLoS One. 2015 Apr 13;10(4):e0122856. doi: 10.1371/journal.pone.0122856. eCollection 2015.

本文引用的文献

4
Aristolochic acid and the etiology of endemic (Balkan) nephropathy.马兜铃酸与地方性(巴尔干地区)肾病的病因
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12129-34. doi: 10.1073/pnas.0701248104. Epub 2007 Jul 9.
9
Use frequency of traditional Chinese medicine in Taiwan.台湾地区中药的使用频率。
BMC Health Serv Res. 2007 Feb 23;7:26. doi: 10.1186/1472-6963-7-26.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验